Birchview Capital as of Dec. 31, 2021
Portfolio Holdings for Birchview Capital
Birchview Capital holds 67 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 30.8 | $48M | 766k | 62.35 | |
Accelr8 Technology | 7.6 | $12M | 2.3M | 5.21 | |
Aziyo Biologics (ELUT) | 5.4 | $8.4M | 1.4M | 5.89 | |
Quidel Corporation | 5.2 | $8.1M | 60k | 134.99 | |
Neurocrine Biosciences (NBIX) | 4.9 | $7.6M | 89k | 85.17 | |
Foghorn Therapeutics (FHTX) | 4.6 | $7.2M | 314k | 22.87 | |
Biodesix (BDSX) | 4.3 | $6.6M | 1.3M | 5.29 | |
ACADIA Pharmaceuticals (ACAD) | 3.0 | $4.7M | 199k | 23.34 | |
United Therapeutics Corporation (UTHR) | 2.5 | $3.9M | 18k | 216.06 | |
Biogen Idec (BIIB) | 1.9 | $3.0M | 13k | 239.92 | |
Albireo Pharma | 1.7 | $2.6M | 113k | 23.29 | |
Masimo Corporation (MASI) | 1.5 | $2.3M | 8.0k | 292.75 | |
Arena Pharmaceuticals | 1.3 | $2.0M | 22k | 92.95 | |
Prothena Corp SHS (PRTA) | 1.3 | $2.0M | 40k | 49.40 | |
Inhibrx | 1.1 | $1.7M | 40k | 43.67 | |
Continental Resources | 1.1 | $1.7M | 39k | 44.77 | |
Biohaven Pharmaceutical Holding | 1.1 | $1.7M | 12k | 137.83 | |
Karyopharm Therapeutics (KPTI) | 1.0 | $1.6M | 246k | 6.43 | |
Harrow Health (HROW) | 1.0 | $1.6M | 180k | 8.64 | |
ImmunoGen | 0.9 | $1.4M | 190k | 7.42 | |
Equitrans Midstream Corp (ETRN) | 0.9 | $1.4M | 133k | 10.34 | |
Nektar Therapeutics (NKTR) | 0.9 | $1.4M | 100k | 13.51 | |
Protagonist Therapeutics (PTGX) | 0.8 | $1.3M | 38k | 34.21 | |
Arvinas Ord (ARVN) | 0.8 | $1.2M | 15k | 82.13 | |
Alkermes SHS (ALKS) | 0.7 | $1.2M | 50k | 23.26 | |
Encana Corporation (OVV) | 0.7 | $1.2M | 34k | 33.71 | |
Cytokinetics (CYTK) | 0.7 | $1.1M | 25k | 45.60 | |
Gossamer Bio (GOSS) | 0.7 | $1.1M | 100k | 11.31 | |
Amarin Corp Spons Adr New (AMRN) | 0.7 | $1.0M | 300k | 3.37 | |
Corcept Therapeutics Incorporated (CORT) | 0.6 | $990k | 50k | 19.80 | |
Vanda Pharmaceuticals (VNDA) | 0.6 | $941k | 60k | 15.68 | |
Bluebird Bio (BLUE) | 0.5 | $839k | 84k | 9.99 | |
Progyny (PGNY) | 0.5 | $755k | 15k | 50.33 | |
Chemocentryx | 0.5 | $728k | 20k | 36.40 | |
2seventy Bio (TSVT) | 0.5 | $718k | 28k | 25.64 | |
Cullinan Oncology (CGEM) | 0.4 | $696k | 45k | 15.43 | |
Pioneer Natural Resources | 0.4 | $691k | 3.8k | 181.84 | |
Zentalis Pharmaceuticals (ZNTL) | 0.4 | $672k | 8.0k | 84.00 | |
Aveo Pharmaceuticals | 0.4 | $657k | 140k | 4.69 | |
Inari Medical Ord (NARI) | 0.4 | $639k | 7.0k | 91.29 | |
Apellis Pharmaceuticals (APLS) | 0.4 | $567k | 12k | 47.25 | |
Kalvista Pharmaceuticals (KALV) | 0.3 | $529k | 40k | 13.22 | |
Contrafect | 0.3 | $526k | 200k | 2.63 | |
Ventyx Biosciences (VTYX) | 0.3 | $497k | 25k | 19.88 | |
Xencor (XNCR) | 0.3 | $493k | 12k | 40.08 | |
Irhythm Technologies (IRTC) | 0.3 | $471k | 4.0k | 117.75 | |
Amicus Therapeutics (FOLD) | 0.3 | $439k | 38k | 11.55 | |
G1 Therapeutics | 0.3 | $408k | 40k | 10.20 | |
Turning Point Therapeutics I | 0.2 | $382k | 8.0k | 47.75 | |
Stoke Therapeutics (STOK) | 0.2 | $360k | 15k | 24.00 | |
Soleno Therapeutics | 0.2 | $360k | 877k | 0.41 | |
Kiniksa Pharmaceuticals | 0.2 | $353k | 30k | 11.77 | |
Silk Road Medical Inc Common | 0.2 | $341k | 8.0k | 42.62 | |
Inflarx Nv (IFRX) | 0.2 | $333k | 70k | 4.76 | |
Tg Therapeutics (TGTX) | 0.2 | $285k | 15k | 19.00 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $277k | 20k | 13.85 | |
Iveric Bio | 0.2 | $251k | 15k | 16.73 | |
Pfizer (PFE) | 0.2 | $236k | 4.0k | 59.00 | |
Laird Superfood (LSF) | 0.2 | $235k | 18k | 13.06 | |
Akebia Therapeutics (AKBA) | 0.1 | $226k | 100k | 2.26 | |
Aspira Womens Health | 0.1 | $182k | 103k | 1.77 | |
Angion Biomedica Corp | 0.1 | $158k | 54k | 2.90 | |
Sientra | 0.1 | $147k | 40k | 3.67 | |
Docgo (DCGO) | 0.1 | $94k | 10k | 9.40 | |
Yield10 Bioscience | 0.1 | $92k | 19k | 4.91 | |
Concert Pharmaceuticals I equity | 0.0 | $63k | 20k | 3.15 | |
Therapeuticsmd | 0.0 | $18k | 50k | 0.36 |